Sex: U
Vaccine: COVID19-2, DTAPIPVHIB, PNC15, RV5
Symptoms: Expired product administered, Irritability, Product storage error
Clinical narrative: fussy that night after vaccines. [Irritable]; doses were given in their facility >12 hours post puncture [Expired vaccine used]; vial was initially stored in the refrigerator on 01-Jun-2023, first punctured on 08-Jun-2023 and was administered with 09-Jun-2023 [Product storage error]; Initial information received on 06-Mar-2024 regarding an unsolicited valid  non-serious Courtesy case received from a other health professional.  This case involves Adult and unknown gender patient who experienced fussy that night after vaccines. [irritable], doses were given in their facility >12 hours post puncture [expired vaccine used] and vial was initially stored in the refrigerator on 01-jun-2023, first punctured on 08-jun-2023 and was administered with 09-jun-2023 [product storage error] while receiving vaccines ROTATEQ, Vaxneuvance, Moderna Covid-19 Vaccine, Bivalent (Original And Omicron Ba.4/Ba.5) And Diphtheria/Tetanus/5 Hybrid Ac Pertussis/Ipv(Vero)/Hib(Prp/T) Vaccine [Pentacel (Vero)].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. At the time of the event, the patient had ongoing Cough with at the time of vaccination and up to one month before), Plagiocephaly (improving)since 12-Jan-2023 and Teething.  Concomitant medications included Ibuprofen (Ibuprofen) for Teething; and Multivitamin [Vitamins Nos] (Multivitamin [Vitamins Nos]).  On 09-Jun-2023, the patient received a dose 3  of suspect Diphtheria/Tetanus/5 Hybrid Ac Pertussis/Ipv(Vero)/Hib(Prp/T) Vaccine (Suspension for injection) lot UJ786AA via intramuscular route in unknown administration site, received a dose 1  of suspect Moderna Covid-19 Vaccine, Bivalent (Original And Omicron BA.4/BA.5) not produced by Sanofi Pasteur lot AS7185B via unknown route in unknown administration site, received a dose 3  of suspect Vaxneuvance not produced by Sanofi Pasteur lot W039033 via intramuscular route in unknown administration site and also received a dose 3  of suspect Rotateq not produced by Sanofi Pasteur lot W039033 (strength, expiry date was unknown for all the suspects) via unknown route in unknown administration site for all Prophylactic vaccination (Immunization)  On 09-JUN-2023 the patient developed a non-serious fussy that night after vaccines. [irritable] (irritability), doses were given in their facility >12 hours post puncture [expired vaccine used] (expired product administered) and vial was initially stored in the refrigerator on 01-jun-2023, first punctured on 08-jun-2023 and was administered with 09-jun-2023 [product storage error] (product storage error) (latency : same day) following the administration of Diphtheria/Tetanus/5 Hybrid Ac Pertussis/Ipv(Vero)/Hib(Prp/T) Vaccine, Moderna Covid-19 Vaccine, Bivalent (Original And Omicron Ba.4/Ba.5), Vaxneuvance And Rotateq.  Action taken was not applicable.  It was not reported if the patient received a corrective treatment for the events (fussy that night after vaccines. [Irritable]).  At time of reporting, the outcome was Unknown for the event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive and Regulatory Authority Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.